Highlights Pacific Biosciences of California, Inc. Börse Stuttgart

Equities

P09

US69404D1081

Real-time Estimate Tradegate Other stock markets 07:00:47 2024-07-03 EDT			5-day change	1st Jan Change
1.186 ^EUR	+7.80%		-18.89%	-88.05%

07-01	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 2500 Growth Index	CI
06-27	PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry	06-27	MT
Form Bio and Pacbio Announce Collaboration to Launch New Resources Set to Transform Aav Design and Analysis Best Practices	06-27	CI
PacBio and International Research Consortium Colors Announce Release of First-Ever HiFi Long-Read Variant Database	06-10	CI
Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes	05-15	MT
Ambry Genetics and PacBio Announces Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases	05-15	CI
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M	05-09	MT
Pacific Biosciences of California, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Sector Update: Health Care Stocks Higher Late Afternoon	04-16	MT
Sector Update: Health Care	04-16	MT
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink	04-16	MT
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	04-16	CI
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	03-27	CI
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions	03-12	CI
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours	02-15	MT
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q4 Revenue $58.4M, vs. Street Est of $58.3M	02-15	MT
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-15	CI
Pacific Biosciences of California, Inc Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale	02-05	CI
PacBio Announces New Nanobind Pandna Kit Enabling Hifi Optimized Dna Extraction Solutions	01-15	CI
Pacific Biosciences Posts Higher Preliminary Q4, Full-Year 2023 Revenue	01-08	MT
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders	11-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pacific Biosciences of California, Inc. Börse Stuttgart

Equities

P09

US69404D1081

Highlights

Filters